Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Oxodipine [inn]
2. 90729-41-2
3. Oxodipine, (+)-
4. Oxodipine, (-)-
5. 2mtw8ysx8g
6. Gpe63j28f0
7. 7t54300ums
8. Ethyl Methyl 1,4-dihydro-2,6-dimethyl-4-(2,3-(methylenedioxy)phenyl)-3,5-pyridinedicarboxylate
9. Oxodipinum [latin]
10. Oxodipino [spanish]
11. Oxodipinum
12. Oxodipino
13. 119914-33-9
14. 119914-34-0
15. 3,5-pyridinedicarboxylic Acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, Ethyl Methyl Ester, (+)-
16. 3,5-pyridinedicarboxylic Acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, Ethyl Methyl Ester, (-)-
17. Iqb-837-v
18. Unii-gpe63j28f0
19. Unii-2mtw8ysx8g
20. Oxodipine [who-dd]
21. 5-o-ethyl 3-o-methyl 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
22. Schembl332244
23. Unii-7t54300ums
24. Iqb-837v
25. Chembl2105319
26. Dtxsid50869063
27. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-, Ethyl Methyl Ester
28. Q7115729
| Molecular Weight | 359.4 g/mol |
|---|---|
| Molecular Formula | C19H21NO6 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 359.13688739 g/mol |
| Monoisotopic Mass | 359.13688739 g/mol |
| Topological Polar Surface Area | 83.1 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 652 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Oxodipine has known human metabolites that include Oxodipine(m1) and Oxodipine(m2).
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
18
PharmaCompass offers a list of Oxodipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxodipine manufacturer or Oxodipine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxodipine manufacturer or Oxodipine supplier.
PharmaCompass also assists you with knowing the Oxodipine API Price utilized in the formulation of products. Oxodipine API Price is not always fixed or binding as the Oxodipine Price is obtained through a variety of data sources. The Oxodipine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxodipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxodipine, including repackagers and relabelers. The FDA regulates Oxodipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxodipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxodipine supplier is an individual or a company that provides Oxodipine active pharmaceutical ingredient (API) or Oxodipine finished formulations upon request. The Oxodipine suppliers may include Oxodipine API manufacturers, exporters, distributors and traders.
Oxodipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxodipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxodipine GMP manufacturer or Oxodipine GMP API supplier for your needs.
A Oxodipine CoA (Certificate of Analysis) is a formal document that attests to Oxodipine's compliance with Oxodipine specifications and serves as a tool for batch-level quality control.
Oxodipine CoA mostly includes findings from lab analyses of a specific batch. For each Oxodipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxodipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxodipine EP), Oxodipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxodipine USP).
